1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Heplisav-B: new trials by email Literature Review of Heplisav-B trials Research Report on Heplisav-B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I) HEPLISAV-B - Hepatitis, Safety and Tolerability | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 78 | 2018-12-07 | 2022-02-08 |
Hepatitis (1)
National Heart, Lung, and Blood Institute (NHLBI) (1)
United States (1)
Christopher MT Pleyer, M.D. (1)